(RTTNews) - Mirum Pharmaceuticals, Inc. (MIRM) announced Monday top-line results of the Phase 2 EMBARK study evaluating LIVMARLI (maralixibat) oral solution versus placebo given as an adjuvant therapy ...

From the moment Jordan and Hillary Weidner began dating seriously, the desire to build a family served as a baseline for their relationship. So when they eventually married in their hometown of ...

Biliary atresia (BA) is the leading cause of liver failure in infants, marked by progressive destruction of the bile ducts. Until the late 1950s, the disease was universally fatal, with no effective ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), today announced top-line results of the Phase 2 EMBARK study evaluating LIVMARLI® (maralixibat) oral solution versus placebo given as an adjuvant therapy to ...

This study found significant inter-hospital variability in the age at which Kasai portoenterostomy for biliary atresia is performed in tertiary children's hospitals in the United States. Improved ...

Biliary atresia (BA) is one of the most devastating biliary diseases affecting newborns and early infants. Coordinated surgical care and systematic long-term monitoring have dramatically improve the ...

Biliary atresia is a rare liver disease where bile ducts become blocked, leading to rapid liver damage in infants. Early diagnosis, ideally within the first 60 days of life, is the single most ...

For a slightly more than one-year-old Nayum from South Africa, the battle against a congenital condition called biliary atresia began soon after his birth. A few days after he was born to Wazir Khan ...